Designer drugs on the Internet : a phenomenon out-of-control? : The emergence of hallucinogenic drug Bromo-Dragonfly
View/ Open
Author
Corazza, Ornella
Schifano, Fabrizio
Farre, Magi
Deluca, Paolo
Davey, Zoe
Drummond, Colin
Torrens, Marta
Demetrovics, Zsolt
Di Furia, Lucia
Flesland, Liv
Mervo, Barbara
Moskalewicz, Jacek
Pisarska, Agnieszka
Shapiro, Harry
Siemann, Holger
Skutle, Arvid
Pezzolesi, Cinzia
van der Kreeft, Peer
Scherbaum, Norbert
Attention
2299/10464
Abstract
Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon